Eli Lilly and Co

LLY

Company Profile

  • Business description

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Contact

    Lilly Corporate Center
    IndianapolisIN46285
    USA

    T: +1 317 276-2000

    E: [email protected]

    https://www.lilly.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    47,000

Eli Lilly and Co News & Analysis

markets

June 2025 US stock market outlook: Has the storm passed?

Be wary of the recent complacency; there’s turbulent water ahead before the skies clear.
markets

US stock market outlook: Where we see opportunities in Q2

A bear market in AI stocks leads to more attractive valuations.
personal-finance

US stock market outlook: tariffs are 2025's wild card

Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,001.4059.900.67%
CAC 407,850.43106.021.37%
DAX 4024,240.82198.920.83%
Dow JONES (US)45,010.29507.851.14%
FTSE 1009,061.4937.680.42%
HKSE25,538.07408.041.62%
NASDAQ21,020.02127.330.61%
Nikkei 22541,171.321,396.403.51%
NZX 50 Index12,809.9815.920.12%
S&P 5006,358.9149.290.78%
S&P/ASX 2008,737.2060.000.69%
SSE Composite Index3,582.300.440.01%

Market Movers